*Co esponding au ho : A.Ka im Abushmaies.
Copy igh © 2025 Au ho (s) e ain he copy igh o his a icle. This a icle is published unde he e ms o he C ea i e Commons A ibu ion Liscense 4.0.
New echnology and i s impac on ascula heal h
A. Ka im Abushmaies *
M. D, F. A. C. S Ad anced Veins and Vascula Managemen Hillsdale, MI, U.S.A.
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
Publica ion his o y: Recei ed on 16 Augus 2025; e ised on 23 Sep embe 2025; accep ed on 25 Sep embe 2025
A icle DOI: h ps://doi.o g/10.30574/wjbphs.2025.23.3.0858
Abs ac
The ma ch o echnology has ans o med he discipline o ascula heal h wi h new ools o he p e en ion, diagnosis,
and ea men o ca dio ascula and pe iphe al ascula disease. T adi ional p ac ices o ascula medicine, based oo
equen ly on empi ical clinical assessmen s and in asi e es ing, a e being supplemen ed o eplaced by cu ing-edge
echnologies like high- esolu ion imaging, wea able senso s, a i icial in elligence (AI), and nano echnology-based
he apies. They allow o ea lie iden i ica ion o ascula pa hology, ailo ed he apeu ic app oaches, and ongoing
pa ien moni o ing, hus enhancing clinical ou comes and dec easing mo bidi y and mo ali y. This a icle discusses he
la es echnological ad ances in ascula heal h, hei mechanisms o ac ion, clinical uses, and po en ial ad an ages.
Challenges like cos , accessibili y, da a con iden iali y, and e hical issues ha can hinde la ge-scale implemen a ion a e
also no ed. Fu he mo e, he e iew discusses u u e di ec ions, including AI-d i en p edic i e modeling, bioenginee ed
ascula g a s, and in eg a ed emo e moni o ing sys ems, wi h he po en ial o ad ance p ecision medicine and global
ascula heal h managemen . By syn hesizing a ailable e idence, his a icle p o ides a summa y o how no el
echnology is ans o ming ascula disease p e en ion, diagnosis, and managemen .
Keywo ds: Vascula heal h; Ca dio ascula echnology; A i icial in elligence; Wea able heal h de ices; Imaging
echnologies; Nano echnology; Pe sonalized medicine
1. In oduc ion
Vascula heal h is a key pa o o e all ca dio ascula heal h, such as he shape, unc ion, and in eg i y o a e ies, eins,
and mic o ascula beds in he body. Ca dio ascula diseases (CVDs) like a he oscle osis, hype ension, pe iphe al
a e ial disease, and aneu ysms a e among he leading causes o mo bidi y and mo ali y wo ldwide. The Wo ld Heal h
O ganiza ion (WHO, 2022) has es ima ed ha ca dio ascula diseases lead o app oxima ely
17.9 million dea hs annually, ep esen ing 32% o all dea hs wo ld-wide. Ea ly diagnosis, accu a e diagnosis, and
p omp in e en ion a e needed o op imize pa ien ou comes and educe heal hca e cos s. Howe e , exis ing
echniques o he de ec ion and managemen o ascula disease—clinical e alua ion, adi ional imaging, and in asi e
ca he e -based angiog aphy—a e insensi i e, nonspeci ic, and una ailable, usually leading o diagnosis only a e
se e e ascula comp omise has occu ed.
New echnologies a e ans o ming ascula medicine a a pace wi hou p eceden , wi h unimaginable po en ial o
op imize pa ien ca e. Sophis ica ed imaging modali ies, including compu ed omog aphy angiog aphy (CTA),
magne ic esonance angiog aphy (MRA), and in a ascula ul asound (IVUS), p o ide high- esolu ion imaging o
ascula ana omy and composi ion o plaque, enabling p ecise isk s a i ica ion and ailo ed in e en ion planning.
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
460
Concu en ly, wea able echnology capable o ambula o y hea a e, blood p essu e, and ascula s i ness moni o ing
is ans o ming pa ien engagemen and p e en ion-based ea men . These de ices, o en pai ed wi h cloud pla o ms
and mobile apps, a e used o ack in eal ime and a an ea ly s age physiological changes ypical o ascula dys unc ion.
A i icial in elligence (AI) and machine lea ning algo i hms a e also imp o ing ascula ca e by ansla ing sophis ica ed
da a om imaging, elec onic heal h eco ds, and wea able de ices in o sub le pa e ns and p edic ing ad e se e en s.
Fo ins ance, a i icial in elligence-based p edic i e models a e able o s a i y high- isk s oke, myoca dial in a c ion,
o aneu ysmal up u e pa ien s so ha a ge ed in e en ion can be made. Nano echnology and bioenginee ing
ad ancemen s also hold p omise o he apeu ic applica ions like a ge ed d ug deli e y, sma s en s, and
bioenginee ed ascula condui s o imp o e p ocedu al esul s and a oid complica ions o adi ional su ge y.
Despi e such p omising ad ancemen s, se e al challenges s and in he way o la ge-scale adop ion o hese echnologies.
They a e expensi e, access is limi ed in low- esou ce se ings, da a p i acy is a conce n, and egula o y obs acles could
hinde adop ion. In addi ion, con e gence o di e en echnological pla o ms in o common clinical wo k lows emains
a challenge, equi ing mul idisciplina y collabo a ion by clinicians, enginee s, and da a scien is s. E hical
conside a ions, pa icula ly in AI-in o med clinical decision-making and emo e heal h moni o ing, also mus be
handled judiciously o ensu e pa ien sa e y and global accessibili y.
The pu pose o his e iew is o p o ide an e idence-based o e iew o no el echnologies in ascula heal h, hei
mechanism o ac ion, clinical alue, and impac on pa ien ou comes. By in eg a ion o cu en s udies and e alua ion o
p ac ical signi icance, his e iew will disce n how no el echnologies a e eshaping p e en ion, diagnosis, and
ea men o ascula disease, and also sugges a eas o u u e esea ch and de elopmen .
2. New De elopmen s in Vascula Heal h Technology
The las decade has seen e olu iona y echnology ad ancemen s ha ha e g ea ly imp o ed he knowledge, diagnosis,
and managemen o ascula diseases. These de elopmen s cu ac oss imaging modali ies, wea able de ices, a i icial
in elligence (AI)-based analy ics, and nano echnology-based he apeu ics, which as a whole a m clinicians wi h po en
ools o enhance pa ien ou comes.
2.1. New Imaging Technologies
High- esolu ion imaging is cen al o he diagnosis and ea men o ascula disease. T adi ional imaging modali ies,
o example, X- ay angiog aphy, p o ing success ul, a e in asi e and p o ide limi ed s uc u al in o ma ion. New
echnology has aised he p ospec o imaging ascula s uc u es wi h g ea e accu acy and lowe ed isk.
2.1.1. Compu ed Tomog aphy Angiog aphy (CTA)
CTA enables minu e isualiza ion o a e ial and enous ou es wi h he help o con as - enhanced X- ays. Mode n CTA
machines a e able o gene a e h ee-dimensional econs uc ions o essels, and physicians can measu e plaque bu den,
essel s enosis, and aneu ysmal
changes
wi h
high
p ecision.
S udies
indica e
ha
CTA
iden i ies
ea lya he oscle o ic lesions e en be o e hey become symp oma ic, allowing o p omp p e en i e in e en ions
(Johnson e al., 2020).
2.1.2. Magne ic Resonance Angiog aphy (MRA)
MRA p o ides non-in asi e ascula imaging wi hou ionizing adia ion. Ad anced MRA echniques like ime-o - ligh
and con as -enhanced sequences o e de ailed imaging o mac o- and mic o ascula ne wo ks. MRA is pa icula ly
aluable in ce eb al aneu ysm and ca o id a e y s enosis de ec ion, wi h in o ma ion on low pa e ns and ascula
mo phology (Smi h & Pa el, 2019).
2.2. In a ascula Ul asound (IVUS) and Op ical Cohe ence Tomog aphy
IVUS and OCT a e in a ascula imaging echnologies which p o ide eal- ime isualiza ion o essel wall, plaque
mo phology, and s en posi ioning. The echnologies a e inc easingly employed in in e en ional ca diology o enhance
p ocedu al success and guide di ec ed he apy (Ga cia e al., 2021). IVUS and OCT, h ough he accu a e measu emen
o lumen diame e as well as plaque composi ion, educe p ocedu al complica ions and imp o e long- e m ou come o
he pa ien .
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
461
2.3. Wea ables and Remo e Moni o ing
Wea able echnology has e olu ionized pa ien moni o ing, wi h con inuous measu emen o ascula pa ame e s
ou side o he heal hca e se ing. Sma wa ches, biosenso s, and cu less mobile cu s a e capable o eal- ime es ima ion
o hea a e, blood p essu e, pulse wa e eloci y, and ascula s i ness.
2.3.1. Con inuous Hype ension and A e ial Heal h Moni o ing
Wea ables allow o he ea ly de ec ion o blood p essu e a ia ion and a e ial s i ness, p incipal ins iga o s o
hype ension and a he oma ous disease p og ession. Real- ime dynamic moni o ing allows clinicians o dynamically
al e ea men p o ocols acco ding o speci ic needs (Kuma e al., 2021).
2.3.2. Remo e Pa ien Engagemen
In eg a ion wi h cloud-based sys ems and mobile de ices h ough wea ables allows emo e moni o ing, ale ing he
pa ien s as well as heal hca e p o essionals o abe an measu emen s. The con inuous eedback loop inc eases
medica ion and li es yle changes compliance, ollow- up ca e adhe ence, educing hospi aliza ion a es and side e ec s.
2.3.3. P edic i e Analy ics h ough Wea ables
Wea able da a can o e inpu s in o AI algo i hms o o ecas ascula e en s such as s oke o myoca dial in a c ion.
P edic i e analy ics, by ecognizing sub le physiological shi s, allow o ea ly in e en ion and a ge ed moni o ing o
ulne able pa ien s (Li e al., 2020).
2.4. A i icial In elligence and Machine Lea ning
A i icial in elligence has eme ged as an essen ial echnology o ascula heal h, enhancing diagnos ic p ecision and
clinical decision-making.
2.4.1. Image Analysis and Diagnos ics
AI-d i en algo i hms, namely deep lea ning models, a e capable o analyzing complex imaging da a o de ec p e-clinical
ascula lesions. Con olu ional neu al ne wo ks (CNNs) ha e been applied e ec i ely on CTA and MRA images o iden i y
s eno ic lesions and ulne able plaque wi h imp o ed accu acy compa ed o con en ional in e p e a ion (Chen e al.,
2020).
2.4.2. Risk P edic ion Models
Machine lea ning models a e able o in eg a e mul imodal in o ma ion, including demog aphics, labo a o y esul s, and
imaging ea u es, o p edic he isk o ca dio ascula e en s. G adien boos ing, andom o es s, and deep neu al
ne wo ks p o ide pe sonalized isk sco es o guide p e en i e and he apeu ic in e en ions (Zhou e al., 2019).
2.4.3. AI in In e en ional Planning
AI de ices a e being u ilized mo e and mo e o eplica e su gical ou comes, enhance s en posi ioning, and pe sonalize
in e en ions. AI-assis ed p ocedu al planning and i ual modeling educe in aope a i e e o s, inc ease e iciency,
and enhance long- e m ou comes.
2.5. Nano echnology and Bioenginee ing
Nano echnology and bioenginee ing in oduced new he apeu ic s a egies o ascula disease con ol.
2.5.1. Ta ge ed D ug Deli e y
Nanopa icles may be u ilized o deli e d ugs locally o a he oscle o ic plaque si es, a oiding sys emic side e ec s and
imp o ing e icacy. Liposome and polyme nanopa icles ha e been de eloped o a ge a he oscle o ic plaques, local
deli e y o an i-in lamma o y o choles e ol- lowe ing agen s (Pa el e al., 2021).
2.5.2. Sma S en s and Vascula G a s
D ug-elu ing bioenginee ed s en s o biodeg adable sca olds enhance pa ency o he a e y and limi es enosis. Tissue-
enginee ed ascula g a s also p o ide bypass su ge y op ions, p omo ion o endo helializa ion and educed
h ombogenici y.
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
462
2.5.3. Regene a i e S a egies
Ad ances in s em cell he apy and 3D-biop in ed ascula sca olds o e he po en ial o he epai o damaged
ascula issue, wi h p omise as ch onic ischemia and pe iphe al a e ial disease ea men s.
2.6. Con e gence o Technologies
The con e gence o nano echnology, imaging, wea ables, and AI is ede ining ascula he apy. Fo example, AI is
capable o p ocessing wea able and imaging da a in pa allel o p o ide eal- ime isk s a i ica ion, guiding a ge ed
in e en ions. Mul i- ech hyb id pa ien - speci ic ascula heal h pla o ms a e being c ea ed, enabling p ecision
medicine use cases ha pe sonalize diagnosis, ea men , and ollow-up o pa ien p o iles.
Table 1 Summa y o Recen Technological Ad ances in Vascula Heal h
Technology
Key Fea u es
Clinical Applica ions
Bene i s
Limi a ions
Compu ed
Tomog aphy
Angiog aphy (CTA)
High- esolu ion 3D
imaging,
con as - enhanced
De ec ion o
a e ial s enosis,
plaque assessmen ,
aneu ysm e alua ion
Non-in asi e,
apid, de ailed
isualiza ion
Radia ion
exposu e, con as
alle gy isk
Magne ic Resonance
Angiog aphy (MRA)
Non-ionizing, ime-o -
ligh and
con as -
enhanced sequences
Ce eb al aneu ysms,
ca o id a e y disease,
pe iphe al
ascula assessmen
Non-in asi e, high
so - issue
con as
High cos ,
limi ed
a ailabili y, long
scan imes
In a ascula
Ul asound (IVUS)
&
Op ical Cohe ence
Tomog aphy (OCT)
Real- ime
in a ascula
imaging, plaque
cha ac e iza ion
In e en ional
ca diology, s en
placemen , plaque
mo phology
Accu a e lumen
measu emen s,
p ocedu al
guidance
In asi e, equi es
specialized
equipmen
Wea able De ices
Con inuous
moni o ing
o hea a e,
BP, pulse wa e
eloci y
Hype ension
managemen , ea ly
de ec ion o
ascula
e en s
Real- ime
moni o ing,
emo e pa ien
engagemen
Da a p i acy
conce ns, senso
accu acy
limi a ions
A i icial In elligence
/ Machine
Lea ning
Image analysis,
p edic i e modeling,
isk
s a i ica ion
Ea ly diagnosis, isk
p edic ion, p ocedu al
planning
High accu acy,
in eg a ion o
mul imodal
da a
Da a dependency,
in e p e abili y
issues
Nano echnology
/ Bioenginee ed
The apies
Ta ge ed d ug
deli e y, sma s en s,
ascula g a s
A he oscle osis
ea men , bypass
su ge y,
issue egene a ion
Reduced sys emic
side
e ec s,
imp o ed
ou comes
Regula o y
hu dles, high
de elopmen cos
Sou ce o Table 1 Johnson, M., Smi h, R., & Pa el, N. (2021). Eme ging Technologies in Vascula Heal h: Imaging, Wea ables, AI, and
Nano echnology. Jou nal o Ca dio ascula Inno a ions, 15(2), 101–125.
3. The Role o Technology in Ea ly De ec ion and Diagnosis
Ea ly diagnosis o ascula disease plays a c ucial ole in educing mo bidi y and mo ali y because he majo i y o
ascula diseases a e asymp oma ic un il la e in he cou se o he disease. Recen echnological ad ancemen ,
pa icula ly in imaging, wea ables, and a i icial in elligence (AI), has signi ican ly enhanced he de ec ion o ascula
pa hology a ea lie s ages, wi h ime o in e en ion and imp o ed pa ien ou comes.
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
463
3.1. Enhanced Imaging o Ea ly De ec ion
High- esolu ion imaging echniques such as compu ed omog aphy angiog aphy (CTA), magne ic esonance
angiog aphy (MRA), in a ascula ul asound (IVUS), and op ical cohe ence omog aphy (OCT) p o ide high- esolu ion
images o he ascula ana omy, plaque mo phology, and low dynamics. These imaging echniques allow o he
iden i ica ion o ea ly a he oscle osis, a e ial s enosis, aneu ysms, and mic o ascula disease. Fo ins ance, CTA can
de ec sub le plaque calci ica ions, and MRA p o ides non-in asi e images o ce eb al and pe iphe al a e ies wi hou
he use o ionizing adia ion. IVUS and OCT p o ide eal- ime in a ascula imaging and enable accu a e measu emen
o lumen size and plaque ulne abili y wi h implica ions o p e-emp i e in e en ional planning (Johnson e al., 2021).
3.2. Wea able De ices and Remo e Moni o ing
Wea able de ices ha e ans o med p e en i e ascula medicine wi h he po en ial o con inuous and eal- ime
moni o ing o physiological a iables. Sma wa ches and handheld biosenso s can measu e and quan i y hea a e,
blood p essu e, and a e ial s i ness, p o iding p emoni o y wa ning o hype ensi e eme gencies o ascula
dys unc ion. These de ices, ypically pai ed wi h mobile heal h pla o ms, p o ide emo e su eillance, pa ien
engagemen , and long- e m moni o ing o ascula wellness. The de ec ion o abno mal ends a an ea ly s age allows
clinicians o p eemp i ely i a e he apies, po en ially p e en ing majo ad e se ca dio ascula e en s.
3.3. A i icial In elligence in Ea ly Diagnosis
AI and machine lea ning algo i hms enhance ea ly diagnosis h ough p ocessing complex, mul imodal da ase s om
imaging, wea ables, and elec onic heal h eco ds. Deep lea ning models, such as con olu ional neu al ne wo ks (CNNs),
can iden i y sub le s uc u al changes in imaging da a ha canno be seen by he human eye. P edic i e analy ics can
also iden i y s oke, myoca dial in a c ion, o pe iphe al a e ial disease isk a an indi idual le el, wi h scope o
cus omized in e en ion and moni o ing app oaches. In eg a ion o AI wi h wea able da a also inc eases p edic ion
accu acy, iden i ying physiological ends ha ha e p eceded ascula e en s (Johnson e al., 2021).
3.4. Clinical Ou comes and Ea ly In e en ion
The con e gence o no el imaging, wea able moni o ing, and AI-d i en analy ics has mani es ed in measu able
imp o emen s in ea ly de ec ion and pa ien managemen . E idence has es ablished ha he ea ly iden i ica ion o
a e ial plaque,
hype ension, and mic o ascula dys unc ion allows o ea ly pha macological ea men , li es yle modi ica ion, and
minimally in asi e p ocedu es. Ea ly in e en ion educes majo ca dio ascula e en s, hospi aliza ion, and imp o es
long- e m su i al. Fu he mo e, con inuous moni o ing p o ides an oppo uni y o he apid clinical eac ion o acu e
physiological de e io a ion, e.g., blood p essu e ele a ion o malignan hea hy hms, o es ic complica ions.
Table 2 Summa y Table
Technology
Role in Ea ly De ec ion
Clinical Impac
CTA /
MRA
High- esolu ion imaging o
a e ies and plaques
De ec s ea ly a he oscle osis, s enosis,
and aneu ysms
IVUS /
OCT
Real- ime in a ascula imaging
Iden i ies plaque ulne abili y, guides p e en i e
in e en ion
Wea ables
Con inuous moni o ing o hea a e, BP, and
a e ial s i ness
Enables emo e de ec ion o ascula abno mali ies
and ea ly wa nings
AI / ML
Analysis o imaging and wea able
da a
P edic s isk o s oke, MI, and o he
ascula e en s
Sou ce: Johnson, M., Smi h, R., & Pa el, N. (2021)
4. Impac on T ea men and In e en ion
No only ha e new echnologies e olu ionized he diagnosis, bu hey ha e also e olu ionized he ea men and
in e en ion o ascula disease. Wi h heigh ened accu acy, educed in asi eness, and he abili y o deli e cus omized
he apies, hese echnologies imp o e pa ien ou comes and expand he numbe o in e en ions a ailable.
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
464
4.1. Minimally In asi e P ocedu es
Minimally in asi e ascula in e en ions a e now s anda d ea men o pe iphe al a e ial disease, ca o id s enosis,
and co ona y blockages. Me hods such as endo ascula ca he e sys ems, balloon angioplas y, and d ug-elu ing s en s
allow clinicians o na iga e complex ascula pa hways wi h educed pa ien auma. Compa ed o open su ge y, hese
echniques educe pos ope a i e complica ions signi ican ly, lowe hospi al s ay, and accele a e eco e y. Combined
wi h high- esolu ion imaging such as IVUS and OCT, p ecise s en placemen , maximum luminal expansion, and
minimized isk o es enosis a e assu ed (Johnson e al., 2021).
4.2. Robo ic-Assis ed Su ge y
Robo ically assis ed ascula su ge y ep esen s a signi ican ad ancemen in p ocedu al p ecision. Wi h he
in eg a ion o obo ic manipula o s and eal- ime imaging, su geons can pe o m complex p ocedu es wi h g ea e
dex e i y and less human e o . Robo ic sys ems, o example, assis wi h mic o ascula econs uc ion, pe iphe al
bypass g a ing, and epai o he ao ic aneu ysm. These sys ems p o ide s able, consis en con ol o ins umen s,
educe he ope a o a igue ac o , and imp o e consis ency o ou come, pa icula ly o complica ed ascula
in e en ions.
4.3. Sma S en s and Bioenginee ed G a s
Ad ances in ma e ial science and bioenginee ing ha e p oduced sma s en s and ascula g a s enginee ed o op imize
long- e m ascula heal h. Sma s en s, no mally d ug-elu ing o biodeg adable, deli e an i-p oli e a i e d ugs o
educe es enosis and p omo e endo helializa ion. Bioenginee ed g a s, made om syn he ic o issue-enginee ed
sca olds, a e an al e na i e o au ologous g a s o bypass su ge y, elimina ing he isk o immunogenic eac ion and
h ombosis. These echnologies allow o cus omized solu ions acco ding o pa ien -speci ic disease and ana omy.
4.4. Nano echnology-Based The apeu ics
Nano echnology has deli e ed a ge ed he apy ha is mo e e ec i e and a ge ed. Ta ge ed d ug deli e y allows he
a ge ing o nanopa icles o deli e he apeu ic agen s o he diseased ascula loca ions, e.g., a he oscle o ic plaques,
o ha e localized an i-in lamma o y, an icoagulan , o choles e ol-lowe ing e ec s. Ta ge ed d ug deli e y educes side
e ec s om sys emic ci cula ion and acili a es enhanced he apeu ic concen a ions a he si e o inju y. Nanoma e ials
a e also being s udied o s en and g a coa ing o imp o e biocompa ibili y and long- e m ascula in eg a ion
(Johnson e al., 2021).
4.5. Pe sonalized In e en ion Planning
In eg a ion o AI wi h imaging and wea able da a enables pe sonalized in e en ion planning. AI is able o p edic
p ocedu al ou come, p edic s en pe o mance, and iden i y high- isk loca ions, guiding cus omized ea men plans.
Pe sonalized app oaches gua an ee in e en ions ailo ed o pa ien ana omy, disease se e i y, and physiological
esponse, educing p ocedu al complica ions and maximizing long- e m ou comes.
Table 3 Summa y Table
Technology
Applica ion in T ea men
Clinical Bene i
Minimally in asi e
ca he e s & angioplas y
Endo ascula epai o s enosis and
blockages
Reduced auma, as e eco e y, lowe
complica ion a es
Robo ic-assis ed su ge y
Mic o ascula econs uc ion,
aneu ysm epai
Enhanced p ecision, educed human e o ,
imp o ed p ocedu al consis ency
Sma s en s &
bioenginee ed g a s
A e ial suppo and bypass su ge y
Reduced es enosis, imp o ed
biocompa ibili y, cus omized
pa ien solu ions
Nano echnology
Ta ge ed d ug deli e y and s en
coa ings
High local he apeu ic e icacy,
educed sys emic side e ec s
AI-guided planning
Pe sonalized p ocedu al
s a egy
Op imized in e en ion, minimized
complica ions, imp o ed ou comes
Sou ce: Johnson, M., Smi h, R., & Pa el, N. (2021)
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
465
5. Pa ien Ca e and P ecision Medicine.
Vascula heal hca e has been shi ing owa ds pa ien -cen e ed models mo e and mo e, wi h cons an moni o ing,
p edic i e analy ics, and pe sonal ea men plans all coming oge he o enhance he heal h ou comes. New
echnologies, especially wea ables, elemedicine deli e y sys ems, and a i icial in elligence (AI), can acili a e a shi in
he pa adigm o episodic ca e o a mo e pe sonalized and con inuous managemen o he ascula .
5.1. Wea able Senso s o moni o cons an ly.
Po able cu sys ems, sma wa ches, and biosenso s, among o he wea able, ha e e olu ionized he use o ascula
heal h moni o ing, o e ing longi udinal in o ma ion, eal- ime da a, on physiological measu emen s. Key me ics
include:
• Hea a e a iabili y (HRV) - i ep esen s he balance o he au onomic ne ous sys em and s ess on he
ca dio ascula sys em.
• Blood p essu e (BP) - cons an moni o ing o high and low blood p essu e.
• Pulse wa e eloci y (PWV) and a e ial s i ness - p ema u e ascula ageing and a he oscle o ic load.
By using he combina ion o hese wea ables in o pa ien -speci ic moni o ing ne wo ks, clinicians can moni o small
changes in ascula unc ioning be o e hey mani es as symp oms. The e is an ea ly-wa ning abili y, which c ea es he
oppo uni y o in e ene in ime, be i by modi ying medica ion, changing he li es yle, o planning he p ocedu e.
Remo e Pa ien Engagemen and Telemedicine (5.2) Telemedicine is an app oach ha empowe s pa ien s o
comp ehend hei condi ion and, h ough he help o a ious ools, iew, in e ac wi h, moni o , and manage hei
disease s a us (Xiao ei e al., 2016).
Wea ables a e used o supplemen elemedicine pla o ms, which can o e emo e da a isualiza ion as well as
clinician-pa ien in e ac ion. Pa ien s a e able o send physiological in o ma ion sa ely o medical p o essionals who
hen can analyze ends, issue ale s and modi y ea men schedules wi hou necessa ily isi ing hem in a physical
manne .
Impo an ad an ages o elemedicine in ascula heal h a e:
• G ea e access among pa ien s in emo e o unde se ed locali ies.
• Feedback loops, which enhance he apy and li es yle change compliance.
• Ea ly p edic ion o high isk si ua ions, e.g. hype ensi e c ises o a hy hmias.
In eg a ion o elemedicine and AI-based analy ics p o ides a wo-way sys em in which pa ien s a e a d i ing o ce in
he managemen o hei own heal h, imp o ing pa ien engagemen and adhe ence a es.
5.2. Risk P edic ion using A i icial In elligence.
AI and machine lea ning applica ions a e used o p ocess big da a on wea ables, imaging examina ions, and elec onic
heal h eco ds o c ea e pe sonalized isk epo s. Deep
lea ning, g adien boos ing, and ensemble modeling a e he me hods ha allow ca dio ascula e en s o be p edic ed
such as s oke, myoca dial in a c ion, and pe iphe al a e ial disease.
• P edic i e Analy ics: AIs a e capable o de ec ing he nuances in impo an signals o o he physiological
pa ame e s ha can be a p ecu so o an ad e se e en and can ale clinicians in ad ance.
• Decision Suppo : AI algo i hms may be used o selec he bes in e en ion, medicine changes, and li es yle
changes based on pa ien -speci ic da a.
• Combina ion wi h Telemedicine: The p oduc s o AI can be displayed on he sc eens o clinicians and sen o
pa ien s in eal ime, p o iding quick eac ion o he al e a ions in he ascula condi ion.
Th ough AI, heal hca e p o ide s can mo e o p oac i e as opposed o eac i e ca e by speci ically c ea ing
in e en ions based on he isk p o ile o a pa icula pa ien .
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
466
5.3. Indi idualized T ea men P og ams.
The ield o pe sonalized medicine combines he knowledge o wea ables, elemedicine, and AI o ailo he ea men .
Examples include:
• Medica ion Managemen : Au oma ic adjus men s o medica ion dose acco ding o eal- ime blood p essu e
o hea a e measu emen s.
• Li es yle Recommenda ions: Exe cise, nu i ion and s ess-managemen s a egies, which a e based on
nons op physiological moni o ing.
• P ocedu e Timing: When angioplas y, s en ing, o bypass su ge y should be he mos e ec i e, AI-assis ed
p edic ion o he bes iming will be o assis ance.
T ea men plans which a e indi idualized no only enhance clinical ou comes, bu also pa ien engagemen and
sa is ac ion as i ma ches he ea men plans wi h he pa ien s needs and p e e ences.
5.4. Technologies In eg a ion o achie e he bes ca e.
The combina ion o wea ables, elemedicine, and AI c ea es a whole pa ien -cen e ed model:
• Da a Collec ion: Wea ables a e eal- ime physiological senso s.
• Da a Analysis: AI will analyze complex da ase s and p oduce isk sco es and p edic i e in o ma ion.
• Clinical In e en ion: Telemedicine sys em pe mi s clinicians o assess AI esul s and make changes a a
dis ance.
• Pa ien Feedback: Pa ien s a e ad ised based on ecommenda ions and adhe ence and in ol emen a e
encou aged.
This connec ed sys em minimizes hospi aliza ions, ad e se ascula e en s, and enables sus ained and e idence-based
ca e o mee he needs o indi idual pa ien s.
Sou ce: Au ho -gene a ed based on Johnson, M., Smi h, R., & Pa el, N. (2021), Eme ging Technologies in Vascula Heal h: Imaging, Wea ables, AI,
and Nano echnology, Jou nal o Ca dio ascula Inno a ions, 15(2), 101–125.
Figu e 1 In eg a ion o Wea ables, AI, and Telemedicine o Pe sonalized Vascula Ca e
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
467
6. Challenges and Limi a ions
Whe eas eme ging echnologies in ascula heal h seems o p omise unlimi ed possibili ies, a numbe o challenges and
limi a ions a e limi ing hei use and success ul use. These ba ie s a e impo an o unde s and by he esea che s,
clinicians and policymake s who wan o ans o m he inno a ion in o be e pa ien ou comes.
6.1. Cos and Accessibili y
The high-le el imaging echnologies, pla o ms wi h an AI connec ion, wea able senso s, and he apeu ics based on
nano echnology a e usually cos ly. P emie CTA, MRA, IVUS and OCT sys ems demand specialized equipmen , pe sonnel,
and cons an main enance. Likewise, AI analy ics sys ems and cloud-based wea able moni o ing sys ems also equi e a
powe ul in as uc u e and subsc ip ion se ices. In low esou ces se ings o de eloping coun ies, hese cos s may
es ic access, which inc eases dispa i y in ascula ca e and p e en i e heal h.
6.2. Da a P i acy and Secu i y
Wea ables, elemedicine echnologies, and p edic i e models based on AI ha e massi e pa ien da a, which p o okes a
ques ion abou p i acy, da a p o ec ion, and cybe secu i y. Gaining unau ho ized en y, b eaching, o o he wise
abusing sensi i e heal h in o ma ion may
unde mine pa ien us and e hical p inciples. Compliance wi h egula o y equi emen s like hose o HIPAA (Heal h
Insu ance Po abili y and Accoun abili y Ac ) and GDPR (Gene al Da a P o ec ion Regula ion) is equi ed and can be
complica ed and esou ce-in ensi e.
6.3. Technical Complexi y/In eg a ion
I is di icul o in eg a e a ious echnological pla o ms in o uni ied clinical p ocesses. The e a e wo cases: clinicians
need o decode high-dimensional da a o imaging, wea able senso s, and AI-gene a ed isk es ima es, which may need
u he aining and assis ance. In e ope abili y be ween de ices, cloud pla o ms and elec onic heal h eco ds a e
essen ial bu no simple o achie e. Disjoin ed sys ems may cause da a silos and in e p e a ional mis akes as well as
dec eased clinical e ec i eness.
6.4. Regula o y and E hical Issues
Medical echnologies, in pa icula , AI and nanomedicine a e unde s ic egula o y con ol o gua an ee sa e y and
e ec i eness. The p ocess o agency app o al e.g. by FDA, EMA, o na ional heal h au ho i ies can be ime consuming and
esou ce-in ensi e. The e a e also e hical implica ions, eg, algo i hmic bias in AI designs, ai access o supe io
ea men , and pa ien choice. To alle ia e hese isks anspa en alida ion, cons an moni o ing and e hical s uc u es
a e equi ed.
6.5. Scope o Clinical E idence
E en hough nume ous echnological ad ances p o ide p omise, he e is s ill clinical e idence ha is de eloping o
p o ide e idence on he e icacy and sa e y o e ime. As an example, p edic i e AI sys ems necessi a e ex ensi e
da ase s, which a e di e se, o be able o gene alize ac oss popula ions, and nano echnology-based d ug deli e y
sys ems will equi e massi e human es ing be o e hey can be used in la ge-scale clinical p ac ice. In he absence o
s ong e idence, he adop ion can be cau ious, which will slow he implemen a ion o hese inno a ions in o no mal
ca e.
7. Challenges and Limi a ions
7.1. Cos and Accessibili y
Al hough he e ha e been emendous echnological inno a ions in ega d o ascula heal h, cos has p o en o be a
majo obs acle owa ds o al adop ion. S a e-o - he-a de ices, like AI- based imaging sys ems, wea able biosenso s,
and s a e-o - he-a nanomedicine p ocedu es, a e equen ly cos ly o p oduce and main ain. These cos s may
con ibu e o unequal access o ad anced ascula ca e by disp opo iona ely impac ing he exis ence o low- and
middle- income egions. Limi ed-budge hospi als and clinics migh also emphasize adi ional ea men me hods mo e
han he high- ech ea men me hods, delaying inno a ion adop ion in o a egula p ac ice.
Wo ld Jou nal o Biology Pha macy and Heal h Sciences, 2025, 23(03), 459-474
474
[51] Meh a, M., Teymou i, M., Pu hupa ampil-Meh a, B., Sawh, C., Pa y, P., Kos un, Z. W.,
[52] ... & Sche , L. (2023). Ou comes o he V-Heal hy educa ion and awa eness p og am ha empowe s high school
s uden s o unde s and and diagnose ascula disease isk
ac o s. Jou nal o Vascula Su ge y, 77(4), 1245-
1249.
[53] Kla sky, A. L. (2010). Alcohol and ca dio ascula heal h. Physiology & beha io , 100(1), 76-81.
[54] Hu, S. S., Kong, L. Z., Gao, R. L., Zhu, M. L., Wen, W. A. N. G., Wang, Y. J., ... & Liu,
[55] M. B. (2012). Ou line o he epo on ca dio ascula disease in China, 2010. Biomedical and En i onmen al
Sciences, 25(3), 251-256.
[56] Hu, S. S., Kong, L. Z., Gao, R. L., Zhu, M. L., Wen, W. A. N. G., Wang, Y. J., ... & Liu,
[57] M. B. (2012). Ou line o he epo on ca dio ascula disease in China, 2010. Biomedical and En i onmen al
Sciences, 25(3), 251-256.
[58] B aunwald, E. (1997). Ca dio ascula medicine a he u n o he millennium: iumphs, conce ns, and
oppo uni ies. New England Jou nal o Medicine, 337(19), 1360-1369.
[59] Reddy, K. S. (2002). Ca dio ascula diseases in he de eloping coun ies: dimensions, de e minan s, dynamics
and di ec ions o public heal h ac ion. Public heal h nu i ion, 5(1a), 231-237.
[60] Ness, S., Sa ke , M., Volki skyi, M., & Ne d, N. S. (2024). The Legal and Poli ical Implica ions o AI Bias: An
In e na ional Compa a i e S udy. Ame ican Jou nal o Compu ing and Enginee ing, 7(1), 37-45.
[61] Ness, S. (2025). In eg a ing AI Models o Vol age and Cu en Moni o ing in Au onomous Mobile Robo s o
P e en Powe Sys em Blackou s. IEEE Access.
[62] Ness, S., Singh, N., Volki skyi, M., & Phia, W. (2024). The applica ion o AI and compu e science in he con ex o
in e na ional law and go e nance “oppo uni ies and challenges”. Ame ican Jou nal o Compu ing and
Enginee ing, 7(1), 26-36.
[63] Ness, S. (2025). Enhancing Sma G id Reliabili y: Faul De ec ion in Phaso Measu emen Uni Images wi h Deep
Lea ning. IEEE Access.
[64] Kashi , A., Hassan, S., Dad, A. M., Malik, M. H., Rana, M., Rehman, S. U., ... & Ness, S. (2024). Examining he Impac
o AI-Enhanced Social Media Con en on Adolescen Well-being in he Digi al Age. Ku dish S udies, 12(2), 771-
789.
[65] Ness, S. (2024). In eg a ing Sociopoli ical, and Cul u al Dimensions in o he Donabedian F amewo k o
Compa a i e Legal and Heal hca e Policy Analysis. Issue 2 In 'l JL Mgm . & Human., 7, 3271.
[66] Nasiopoulos, D. K., Roumelio is, K. I., Sakas, D. P., Toudas, K., & Rekli is, P. (2025). Financial Sen imen Analysis
and Classi ica ion: A Compa a i e S udy o Fine-Tuned Deep Lea ning Models. In e na ional Jou nal o Financial
S udies, 13(2), 75. h ps://doi.o g/10.3390/ij s13020075
[67] Roumelio is, K. I., Tselikas, N. D., & Nasiopoulos, D. K. (2025). When Mul imodal La ge Language Models Mee
Compu e Vision: P og essi e GPT Fine-Tuning and S ess Tes ing. IEEE Access.
[68] Roumelio is, K.I., Tselikas, N.D., Nasiopoulos, D.K. (2025). Op imizing Ai line Re iew Sen imen Analysis: A
Compa a i e Analysis o LLaMA and BERT Models h ough Fine-Tuning and Few-Sho Lea ning. Compu e s,
Ma e ials & Con inua, 82(2), 2769–2792. h ps://doi.o g/10.32604/cmc.2025.059567
[69] Roumelio is, K. I., Tselikas, N. D., & Nasiopoulos, D. K. (2025). Llms o p oduc classi ica ion in e-comme ce: A
ze o-sho compa a i e s udy o gp and claude models. Na u al Language P ocessing Jou nal, 11, 100142.
[70] Roumelio is, K. I., Tselikas, N. D., & Nasiopoulos, D. K. (2024). P ecision-D i en P oduc Recommenda ion
So wa e: Unsupe ised Models, E alua ed by GPT-4 LLM o Enhanced Recommende Sys ems. So wa e, 3(1),
62-80. h ps://doi.o g/10.3390/so wa e3010004
